Charming Medical Ltd. Faces Class Action Over Alleged Stock Manipulation During IPO Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: Globenewswire
- Lawsuit Notification: Wolf Haldenstein Adler Freeman & Herz LLP has alerted investors who purchased Charming Medical (NASDAQ: MCTA) shares between October 21 and November 12, 2025, that a federal securities class action has been filed, with a lead plaintiff application deadline of February 17, 2026.
- Price Surge: Following its IPO, Charming Medical's stock price surged from $4.00 to $29.36 per share without any fundamental news, indicating an artificial price increase that raises concerns about market integrity.
- Fraud Allegations: The lawsuit alleges that the stock price increase was driven by a fraudulent social media promotion scheme, where impersonators posing as financial advisors made sensational and unsupported claims to induce retail investor buying.
- Trading Suspension: In November 2025, trading of Charming Medical securities was suspended, revealing the artificial nature of the price surge and resulting in significant investor losses, prompting the class action to seek compensation for affected investors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
